Summary
We compared the effects of digitoxin (lipophilic) and ouabain (hydrophilic) in rats under pentobarbital anaesthaesia on inotropy (dp/dt) and atrioventricular conduction (PR-interval). Doses of the glycosides which produced a 40–50% increase in dp/dt produced a significantly greater prolongation of the PR interval with ouabain than with digitoxin. Neither vagotomy nor atropine administration abolished this difference, but the difference could be eliminated by pre-treatment with propranolol. We concluded that the smaller effect of digitoxin on atrioventricular (AV) conduction was due to a central sympathomimetic effect which does not occur with ouabain.
A respiratory depressant effect of digitalis has been reported in humans. We therefore compared the effect of acetyldigitoxin (relatively lipophilic) to that of digoxin (relatively hydrophilic) on the hyper-ventilatory response to inhaled CO2 in healthy volunteers. We found that at mean steady state levels of 12.5 ± 1.07 ng/ml (digitoxin) and 0.87 ± 0.2 ng/ml (digoxin), digitoxin appeared to stimulate ventilation as measured by minute ventilation and oxygen consumption and digoxin appeared to depress ventilation. These observations appear to be consistent with a sympathomimetic effect of the acetyldigitoxin as observed in our animal experiments. It might also be consistent with a greater vagomimetic effect with digoxin as suggested by Runge in 1977. Further research is currently being done to elucidate the mechanisms of the observed differences.
These findings suggest that when cardiac glycosides are used for supraventricular tachyarrhythmias a more hydrophilic cardiac glycoside might be indicated. If on the other hand digitalis is used for its positive inotropic effect, the use of a lipophilic cardiac glycoside might reduce the risk of atrioventricular block. It also seems that if digitalis is used in patients with respiratory impairment, a more lipophilic cardiac glycoside might be preferable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alken R, Belz G (1984) A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. J Cardiovasc Pharmacol 6: 634–640
Aravanis C, Luisada A (1958) Clinical comparison of six digitalis preparations by the parenteral route. Am J Cardiol 74: 706–716
Batterman RC et al (1950) The comparative value of gitalin and other digitalis preparations. Fed Proc 9: 256–261
Eicha LW, Taube H (1943) A comparison of the actions of four cardiac glycosides on a patient with congestive heart failure. Am Heart J 26: 631–644
Hoffman BF, Bigger JT (1980) In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 6th Edition. MacMillan, New York, pp 748–749
Joubert P, van der Meer L (1979) A specific cardiac glycoside for cardiac failure and another for atrial fibrillation. S Afr Med J 56: 1040–1042
Joubert PH et al (1985) Effects of digoxin and acetyl-digitoxin on basal and CO2-stimulated ventilation. Eur J Clin Pharmacol 28: 155–158
Riggert H, Schwab M (1955) Der Einfluß von Digitoxin auf die Atmung des herzgesunden Menschen. Z ges Exp Med 125: 80–92
Runge T (1977) Clinical implications of differences in pharmacodynamic action of polar and non-polar cardiac glycosides. Am Heart J 93: 248–255
Runge T et al (1975) Pharmacodynamic distinctions between ouabain, digoxin and digitoxin. Arch Int Pharmacodyn 214: 31–45
Scott Cook L et al (1982) Adrenergic and cholinergic mechanisms in digitalis inotropy. J Pharm Exp Therap 223: 761–765
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Joubert, P.H. (1986). Evidence for pharmacodynamic differences between cardiac glycosides of different polarities. In: Erdmann, E., Greef, K., Skou, J.C. (eds) Cardiac Glycosides 1785–1985. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-11292-2_28
Download citation
DOI: https://doi.org/10.1007/978-3-662-11292-2_28
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-662-11294-6
Online ISBN: 978-3-662-11292-2
eBook Packages: Springer Book Archive